BioScreening - organic compounds for screening

30.07.2003 July 2003 News Archive

7/30/03 - ACLARA BioSciences
Entered into an eTag™ access agreement with GlaxoSmithKline, under which GSK will have access to ACLARA's eTag Assay System. In addition to ACLARA's custom assay development services, GSK , will also utilize eTag assay reagent products and software for multiplexed gene expression profiling studies.

7/18/03 - Accelrys
Has released its first Discovery Studio™ cheminformatics desktop product, DS Accord for Microsoft® Excel. DS Accord for Excel will allow chemists to see, sketch, analyze, and report chemical structures, compound libraries, screening results and other chemical information directly within the Microsoft Excel environment.

7/18/03 - Zinsser Analytic
Have launched the LISSY 2002, a modular robotic system that combines sophisticated and flexible liquid handling (incorporating a new type of dosage pump) into a robotic arm, which moves on an x-rail to access the workbench or external modules.

7/15/03 - 4SC and Esteve
Announced a collaboration to identify drug candidates directed at targets of CNS related diseases.

7/14/2003 - Caliper Technologies
Completed acquisition of the Zymark Corporation which has become a wholly-owned subsidiary of Caliper and will continue to sell products under its own name.

7/10/2003 - ChemNavigator
Announced that its iResearch Library has grown to include over 10 million chemical samples from over 100 commercial, government, and academic supplier sources around the world.

7/7/2003 - Array Biopharma
Signed a collaboration agreement with GenPath Pharmaceuticals Inc. to identify cancer drugs that target a novel tumor maintenance gene discovered in GenPath's genetic model systems. Array will receive research funding and receive milestone payments based on the selection and progress of a development candidate.

7/1/2003 - Accelrys
The wholly owned subsidiary of Pharmacopeia announced release of Catalyst® 4.8, the latest version of its market-leading rational drug design application for lead identification and optimization.

7/1/2003 - Argonaut Technologies
Announced introduction of a new reagent to accelerate pharmaceutical drug discovery. This new resin-bound reagent, MP-TsO-TEMPO enables medicinal chemists working in drug discovery to efficiently introduce diversity into chemical libraries with high purity and superior yield. Results obtained using MP-TsO-TEMPO resin were presented at the Second European Symposium on Combinatorial Sciences being held in Copenhagen, Denmark from June 29 - July 3, 2003.

new | june 2010 | october 2009 | may 2009 | january 2009 | october 2008 | april 2008 | january 2008 | october 2007 | september 2007 | august 2007 | march 2007 | february 2007 | january 2007 | december 2007 | september 2006 | august 2006 | july 2006 | june 2006 | may 2006 | april 2006 | march 2006 | january 2006 | november 2005 | august 2005 | july 2005 | june 2005 | may 2005 | april 2005 | march 2005 | december 2005 | november 2004 | october 2004 | september 2004 | august 2004 | july 2004 | june 2004 | may 2004 | april 2004 | march 2004 | february 2004 | january 2004 | december 2004 | november 2003 | october 2003 | september 2003 | august 2003 | july 2003 | june 2003 | may 2003